|
Apr 17
|
Down -48.7% in 4 Weeks, Here's Why Seres Therapeutics (MCRB) Looks Ripe for a Turnaround
|
|
Mar 14
|
Seres Therapeutics, Inc. (NASDAQ:MCRB): Are Analysts Optimistic?
|
|
Mar 14
|
Seres Therapeutics Inc (MCRB) Q4 2024 Earnings Call Highlights: Financial Improvements and ...
|
|
Mar 14
|
Q4 2024 Seres Therapeutics Inc Earnings Call
|
|
Mar 13
|
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
|